文献速递颈动脉与弓上血管

溶栓后颈动脉干预围术期结局的系统综述与Meta分析

A Systematic Review and Meta-analysis of Peri-Procedural Outcomes in Patients Undergoing Carotid Interventions Following Thrombolysis.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2021-07-12

CEA后围术期卒中/死亡率为5.2%,颅内出血(ICH)为3.4%;CAS后分别为14.9%和5.5%。病例对照研究显示溶栓后CEA的ICH和局部血肿显著增加,CAS的卒中/死亡和ICH均显著增加,且CEA距溶栓时间与卒中/死亡风险呈负相关。

要点

  • 溶栓后CEA的围术期ICH(3.4%)和局部血肿风险显著高于未溶栓者。
  • 溶栓后CAS的围术期卒中/死亡(14.9%)和ICH(5.5%)风险均显著升高。
  • CEA距溶栓时间与卒中/死亡风险负相关,建议溶栓后6-7天再行CEA。

核心结论

  • 溶栓后CEA的围术期ICH和局部血肿显著更常见,但无随机对照比较。
  • 溶栓后CAS的围术期风险也显著更高。
  • CEA距溶栓时间与围术期卒中/死亡呈负相关,提示溶栓后6-7天再行CEA可能更安全。

研究设计与样本

  • 系统综述与Meta分析,检索Medline、Scopus和Cochrane数据库。

主要发现

  • CEA后汇总围术期卒中/死亡率为5.2%(95%CI 3.3-7.5),ICH为3.4%(95%CI 1.7-5.6)。
  • CAS后汇总围术期卒中/死亡率为14.9%(95%CI 11.9-18.2),ICH为5.5%(95%CI 3.7-7.7)。
  • 病例对照研究中,溶栓后CEA的ICH显著更高(2.2% vs 0.12%;OR 7.82,95%CI 4.07-15.02),局部血肿也更常见(3.6% vs 2.26%;OR 1.17,95%CI 1.17-2.33)。
  • 病例对照研究中,溶栓后CAS的卒中/死亡显著更高(5.2% vs 1.5%;OR 8.49,95%CI 2.12-33.95),ICH也显著更高(5.4% vs 0.7%;OR 7.48,95%CI 4.69-11.92)。

关键数值与推荐

  • CEA后围术期卒中/死亡5.2%(95%CI 3.3-7.5),ICH 3.4%(95%CI 1.7-5.6)。
  • CAS后围术期卒中/死亡14.9%(95%CI 11.9-18.2),ICH 5.5%(95%CI 3.7-7.7)。
  • 溶栓后CEA的ICH风险OR 7.82(95%CI 4.07-15.02),局部血肿OR 1.17(95%CI 1.17-2.33)。
  • 溶栓后CAS的卒中/死亡OR 8.49(95%CI 2.12-33.95),ICH OR 7.48(95%CI 4.69-11.92)。

临床怎么用

  • 溶栓后需行颈动脉干预者应仔细评估风险,尤其关注ICH和局部血肿。
  • 若选择CEA,可考虑推迟至溶栓后6-7天以降低围术期卒中/死亡风险。
  • 溶栓后CAS的围术期风险较高,决策时需权衡获益与风险。

局限性

  • 无随机对照比较,证据主要来自观察性研究和病例对照研究。
  • 各研究间可能存在异质性,影响汇总结果的可靠性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the safety of carotid artery stenting (CAS) and carotid endarterectomy (CEA) after thrombolytic therapy (TT). DATA SOURCES: Medline, Scopus, and Cochrane databases. REVIEW METHODS: Systematic review and meta-analysis of studies involving patients who underwent CEA/CAS after TT. RESULTS: In 25 studies (n = 147 810 patients), 2 557 underwent CEA (n = 2 076) or CAS (n = 481) following TT. After CEA, the pooled peri-procedural stroke/death rate was 5.2% (95% confidence interval [CI] 3.3 - 7.5) and intracranial haemorrhage (ICH) was 3.4% (95% CI 1.7 - 5.6). After CAS, the pooled peri-procedural stroke/death rate was 14.9% (95% CI 11.9 - 18.2) and ICH was 5.5% (95% CI 3.7 - 7.7). In case control studies comparing CEA outcomes in patients receiving TT vs. no TT, peri-procedural death/stroke was non-significantly higher after TT (4.3% vs. 1.5%; odds ratio [OR] 2.34, 95% CI 0.74 - 7.47), but ICH was significantly higher after TT (2.2% vs. 0.12%; OR 7.82, 95% CI 4.07 - 15.02), as was local haematoma formation (3.6% vs. 2.26%; OR 1.17, 95% CI 1.17 - 2.33). In case control studies comparing CAS outcomes in patients receiving TT vs. no TT, peri-procedural stroke/death was significantly higher after TT (5.2% vs. 1.5%; OR 8.49, 95% CI 2.12 - 33.95) as was ICH (5.4% vs. 0.7%; OR 7.48, 95% CI 4.69 - 11.92). Meta-regression analysis demonstrated an inverse association between the time interval from intravenous (IV) TT to undergoing CEA and the risk of peri-procedural stroke/death (p = .032). Peri-operative stroke/death was 13.0% when CEA was performed three days after TT and 10.6% when performed four days after TT, with the risk reducing to within the currently accepted 6% threshold after six-seven days had elapsed. CONCLUSION: Peri-procedural ICH and local haematoma were significantly more frequent in patients undergoing CEA after TT (vs. no TT), although there were no randomised comparisons. Peri-procedural hazards were also significantly higher for CAS after TT. The inverse relationship between timing to CEA and peri-procedural stroke/death mandates careful patient selection and suggests that it may be safer to defer CEA for six-seven days after TT.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Kakkos SK, Vega de Ceniga M, Naylor R, et al. A Systematic Review and Meta-analysis of Peri-Procedural Outcomes in Patients Undergoing Carotid Interventions Following Thrombolysis. Eur J Vasc Endovasc Surg. 2021. PMID: 34266765. doi:10.1016/j.ejvs.2021.06.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。